PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
18672868-0	2008	Synthesis, biological evaluation, and molecular modeling of abiraterone analogues: novel CYP17 inhibitors for the treatment of prostate cancer.	abiraterone	60-71	cytochrome P450 family 17 subfamily A member 1	Homo sapiens	89-94	
18672868-1	2008	Abiraterone, a steroidal cytochrome P450 17alpha-hydroxylase-17,20-lyase inhibitor (CYP17), is currently undergoing phase II clinical trials as a potential drug for the treatment of androgen-dependent prostate cancer.	abiraterone	0-11	cytochrome P450 family 17 subfamily A member 1	Homo sapiens	84-89